Clinical Trials Directory

Trials / Completed

CompletedNCT03073902

The Correlation of PD-L1 Expression in Non-small Lung Cancer Tissue and Peripheral Blood T Cell and Serum.

Clinical Research for the Correlation of PD-L1 Expression in Non-small Lung Cancer Tissue and Peripheral Blood T Cell and Serum.

Status
Completed
Phase
Study type
Observational
Enrollment
80 (actual)
Sponsor
Xinqiao Hospital of Chongqing · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The detection of tissue PD-L1 immunohistochemistry in Non-small cell lung cancer (NSCLC) has an important role in guiding for the treatment of immune detection point. At the same time,tissue detection is time-consuming and laborious, liquid biopsy can reflect the information of tumor tissue,PD-L1 expression in serum and peripheral blood T cell are expected to be simple, rapid, non-invasive means of detection. The project is planned to explore the correlation of PD-L1 expression in non-small lung cancer tissue and peripheral blood T cell and serum..The investigators have designed to detected the expression levels of PD-L1 protein in cancer tissue and detected the expression levels of PD-L1 in peripheral blood T cell and serum.By using variance analysis of repeated measures design information. Thus exploring the correlation of PD-L1 expression in non-small lung cancer tissue and peripheral blood T cell and serum,guiding clinical practice of immunotherapy.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTLiquid biopsyLiquid biopsy

Timeline

Start date
2017-03-25
Primary completion
2018-03-31
Completion
2018-12-10
First posted
2017-03-08
Last updated
2018-12-28

Locations

1 site across 1 country: China

Source: ClinicalTrials.gov record NCT03073902. Inclusion in this directory is not an endorsement.